Apos Medical Assets Ltd. is a global medical device company, owned by leading healthcare fund aMoon and operating in four countries: the United States, the United Kingdom, and Israel.
Founded in 2005, the company distributes the AposTherapy® program to both large hospitals and private clinicians’ practices. To date, over 98,000 patients have used AposTherapy®, worldwide.
The company adheres to high clinical and scientific standards. Dozens of peer-reviewed papers have been published, providing proof of concept of the knee treatment’s mechanism of action as well as giving scientific backing to the positive clinical effects of AposTherapy®.
Musculoskeletal pathologies of the knees and low back are characterized by an increased load on the problematic areas and poor muscle control, causing pain and difficulty in performing daily activities such as walking and using the stairs.
AposTherapy® is an innovative program that uses a personalized footworn device administered by specially trained clinicians.
AposTherapy® improves biomechanical and neuromuscular function by simultaneously reducing the load on the affected area of the joint and strengthening the muscles to retain the improved movement patterns – providing long-term “carry over” results that keep even while not wearing the device.
By improving body mechanics and muscular coordination, AposTherapy® has been shown, in clinical studies, to relieve knee pain and improve daily function and quality of life.
AposTherapy® can be an alternative to surgery for patients who want, or need, a non-invasive approach.
Get back to what you love to do
Schedule a call with our customer care professionals.
Find an AposTherapy® provider near you.